JUSTIN BALLARD: Open Payments
NPI 1013283324 · WELLINGTON, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$664 in 58 payments from 5 companies in 2025. Trend: 2023 $642 · 2024 $552 · 2025 $664
Food & beverage: $564Education: $100
| Company | Payments | Amount |
|---|---|---|
| Sumitomo Pharma America, Inc. | 31 | $217 |
| Endo USA, Inc. | 14 | $204 |
| Janssen Biotech, Inc. | 10 | $170 |
| Astellas Pharma US Inc | 2 | $53 |
| PFIZER INC. | 1 | $20 |
Products named: GEMTESA, ERLEADA, AVEED, XTANDI, XIAFLEX.
Industry payments across FL — which companies pay providers there.
